Science
-
Research updates, June 2
The COVID-19 antiviral ensitrelvir (Xocova), was recently approved by the Food and Drug Administration. The oral drug was approved as PEP, or post-exposure prophylaxis, meaning it is taken within 72 hours after coming in contact with someone who has COVID-19.
-
PolyBio’s Spring 2026 symposium: Advancing Long COVID biomarkers and treatments
The PolyBio Research Foundation recently announced new initiatives and centered biomarkers during their latest virtual conference.
-
International ME/CFS Conference roundup: Setbacks and new hopes for therapeutic research
More than 50 experts from around the world presented the latest findings in basic and therapeutic research on myalgic encephalomyelitis (ME) and Long COVID at a conference in Berlin.
-
Research updates, May 26
More research articles
-
Mold exposure can trigger and worsen chronic illness. Climate change will increase the risk.
Almost half of buildings in the U.S. have mold or dampness, which can cause respiratory symptoms and may even trigger diseases like myalgic encephalomyelitis (ME).
-
Research updates, May 19
More research updates
-
Breaking the vicious cycle: How two German scientists seek to solve ME
A “unifying” hypothesis of the mechanisms, triggers, and risk factors for myalgic encephalomyelitis (ME), is gaining support. Further evaluation and development of a potential drug depend on funding.
-
RECOVER’s first round of clinical trials are failing. Will the next phase be better?
The NIH studies found that Paxlovid, ivabradine, and computer games did not significantly improve symptoms of Long COVID. Further analysis that may help future research research has not yet been released.
-
Research updates, May 12
-
COVID-19 spreads year round. Here’s how to track it.
Our webinar answered common questions about following data for COVID-19 and other infectious diseases.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance